About EchoSens
EchoSens is a company based in Paris (France) founded in 2001 was acquired by Astorg Partners in March 2018. EchoSens has raised $32.75 million across 2 funding rounds from investors including Orbimed, European Union and Inner Mongolia Furui Medical Science. EchoSens operates in a competitive market with competitors including Mauna Kea Tech, CapsoVision, Smart Medical Systems, Invendo Medical and Fibronostics, among others.
- Headquarter Paris, France
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$32.75 M (USD)
in 2 rounds
-
Latest Funding Round
$100.97 K (USD), Grant
Jan 01, 2020
-
Investors
Orbimed
& 4 more
-
Employee Count
Not available
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of EchoSens
Unlock access to complete
Funding Insights of EchoSens
EchoSens has successfully raised a total of $32.75M across 2 strategic funding rounds. The most recent funding activity was a Grant round of $100.97 thousand completed in January 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in EchoSens
EchoSens has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Orbimed, European Union and Inner Mongolia Furui Medical Science.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Locked | Locked | Locked | |
|
Cathay Capital is engaged in global investment and transformation.
|
Locked | Locked | Locked | |
|
Astorg is engaged in private equity investment management.
|
Locked | Locked | Locked |
Investor details for EchoSens
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by EchoSens
Investment portfolio details for EchoSens
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - EchoSens
Detailed financials for EchoSens
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Echosens Comparisons
Peer comparison for EchoSens
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of EchoSens
EchoSens operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Mauna Kea Tech, CapsoVision, Smart Medical Systems, Invendo Medical and Fibronostics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Endomicroscopy devices are developed for gastrointestinal and respiratory endoscopy.
|
|
| Locked | Locked | Locked |
GI capsule endoscopy systems are developed for intestinal imaging.
|
|
| Locked | Locked | Locked |
Endoscopes and devices for GI diagnosis and treatment are produced.
|
|
| Locked | Locked | Locked |
Sterile single-use robotics-based endoscopes are developed for gastroenterology.
|
|
| Locked | Locked | Locked |
Non-invasive algorithm-based diagnostics
|
Detailed competitors of EchoSens
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Echosens
Complete news archive for EchoSens
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about EchoSens
EchoSens was founded in 2001 and raised its 1st funding round 14 years after it was founded.
EchoSens is headquartered in Paris, France.
EchoSens is a funded company, having raised a total of $32.75M across 2 funding rounds to date.
EchoSens was established in 2001 in Paris, France, within the medical diagnostics sector. Non-invasive products for detecting liver conditions, including fibrosis and steatosis, are developed and offered. FibroScan technology is employed to assess liver health without invasive procedures. Operations center on advancing diagnostic tools for healthcare providers across Europe and beyond, with a focus on liver disease evaluation.
EchoSens's top competitors include CapsoVision, Mauna Kea Tech and Inner Mongolia Furui Medical Science.
EchoSens has 5 investors. Key investors include Orbimed, European Union, Inner Mongolia Furui Medical Science, Cathay Capital, and Astorg.